Sanofi

YTD

ALL

Why Robinhood?

You can watch Sanofi and buy or sell other stocks, ETFs, and their options commission-free!

About SNY

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the Biopharma segment, which comprises commercial operations and research, development and production activities relating to the specialty care, general medicines and vaccines franchises plus support and corporate functions, for all geographical territories.

CEO

Belén Garijo López

CEOBelén Garijo López

Employees

76,493

Employees76,493

Headquarters

Paris, Ile-de-France

HeadquartersParis, Ile-de-France

Founded

1994

Founded1994

Employees

76,493

Employees76,493

SNY Key Statistics

Market cap

102.64B

Market cap102.64B

Price-Earnings ratio

22.09

Price-Earnings ratio22.09

Dividend yield

4.10%

Dividend yield4.10%

Average volume

3.51M

Average volume3.51M

High today

$42.91

High today$42.91

Low today

$42.53

Low today$42.53

Open price

$42.83

Open price$42.83

Volume

1.59M

Volume1.59M

52 Week high

$52.68

52 Week high$52.68

52 Week low

$40.89

52 Week low$40.89

SNY News

TipRanks 4h

Sanofi India posts robust Q2 2026 results, revamps board committees

Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and...

TipRanks 5h

Nurix earns $10M milestone from Sanofi on STAT6 degrader Phase 1 start

Nurix Therapeutics (NRIX) announced that it has earned a $10M milestone payment following the initiation by its collaborator, Sanofi, of the Phase 1 first-in-hu...

TipRanks 13h

Sanofi Wins EU Nod to Use MenQuadfi in Infants From Six Weeks

Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and...

Analyst ratings

57%

of 7 ratings

Buy

42.9%

Hold

57.1%

Sell

More SNY News

The Wall Street Journal 4d

Health Care Roundup: Market Talk

Yves Herman / Reuters The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET....

Benzinga 5d

Sanofi Says Weak Decision-Making Hurt Pipeline, Promises More Disciplined R&D

Dupixent Drives Growth While Vaccines Sales Decline Dupixent sales increased by 37.6% to 5.154 billion euros, above 5 billion euros per quarter for the first t...

TipRanks 5d

Sanofi Publishes 2026 Half-Year Financial Report for Investors - TipRanks

...

TipRanks 5d

Sanofi Stock Slips As Key Trial Gets Suspended - TipRanks

...

Nasdaq 5d

Sanofi Q2 Earnings Call Highlights

Sanofi (NASDAQ:SNY) raised its 2026 outlook after reporting double-digit second-quarter sales and earnings growth, driven by Dupixent, recently launched medicin...

TipRanks 5d

Sanofi reports Q2 business EPS EUR 2.09, up 31.4% reported

Business EPS was EUR 2.09, up by 33.3% at CER; 31.4% at actual exchange rates; IFRS EPS EUR 0.29. Reports net sales EUR 11.6B, up 16% reported and 17.8% at CER....

Nasdaq 6d

Sanofi Q2 Net Profit Plunges, Business Profit Climbs On Strong Sales; Lifts FY26 Outlook

(RTTNews) - French drug major Sanofi SA (SNY, SNYNF, SAN.PA) reported Thursday sharply lower net profit in its second quarter, while business earnings climbed f...

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.